Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMIGD3 | P0DMS9 | 1/20 | 0.52 |
| ▸ | ELOVL1 | Q9BW60 | 1/20 | 0.50 |
| ▸ | CCNE1 | P24864 | 4/20 | 0.49 |
| ▸ | CDK2 | P24941 | 4/20 | 0.49 |
| ▸ | CDK5 | Q00535 | 4/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | IKBKB | O14920 | 1/20 | 0.45 |
| ▸ | WNT3A | P56704 | 1/20 | 0.45 |
| ▸ | PRKACA | P17612 | 1/20 | 0.44 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.44 |
| ▸ | GLS | O94925 | 1/20 | 0.44 |
| ▸ | RORC | P51449 | 1/20 | 0.44 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12839938 | 0.93 | KMT2A (0.48) | TMIGD3ELOVL1CCNE1CDK2CDK5 | |
| SCHEMBL12838905 | 0.93 | DEGS1 (0.49) | TMIGD3ELOVL1CCNE1CDK2CDK5 | |
| SCHEMBL12839944 | 0.92 | TMIGD3 (0.45) | TMIGD3ELOVL1CCNE1CDK2CDK5 | |
| SCHEMBL12839937 | 0.92 | NPC1 (0.48) | TMIGD3ELOVL1CCNE1CDK2CDK5 | |
| SCHEMBL12840484 | 0.92 | TMIGD3 (0.45) | TMIGD3ELOVL1CCNE1CDK2CDK5 | |
| SCHEMBL12839932 | 0.92 | KMT2A (0.47) | TMIGD3ELOVL1KMT2AMEN1NPC1 | |
| SCHEMBL12839167 | 0.92 | MAPK14 (0.48) | TMIGD3ELOVL1CCNE1CDK2CDK5 | |
| SCHEMBL12838964 | 0.90 | SMN1; SMN2 (0.53) | CDK5KMT2AMEN1NPC1RAB9A | |
| SCHEMBL12840353 | 0.89 | RIOK2 (0.54) | KMT2AMEN1WNT3A | |
| SCHEMBL12840351 | 0.88 | MAPT (0.47) | KMT2AMEN1NPC1RAB9AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110070656-A1 | Fluorescent Proteins | JNC CORPORATION (JP) | 2011-03-24 | — | — | US | disclosed |
| EP-1666488-B1 | FLUORESCENT PROTEIN | CHISSO CORP (JP) | 2010-11-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110070656-A1 | Fluorescent Proteins | CACYBP, CHLSN, LCP2 | TMIGD3 1782/4885ELOVL1 3538/4885CCNE1 3846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.